Notice: This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HSGX vs. LAKE, INGN, ZJYL, MLSS, NTRB, APT, RBOT, SPAI, CLGN, and COCHShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Lakeland Industries (LAKE), Inogen (INGN), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Vicarious Surgical (RBOT), Safe Pro Group Inc. Common Stock (SPAI), CollPlant Biotechnologies (CLGN), and Envoy Medical (COCH). Histogenics vs. Lakeland Industries Inogen Jin Medical International Milestone Scientific Nutriband Alpha Pro Tech Vicarious Surgical Safe Pro Group Inc. Common Stock CollPlant Biotechnologies Envoy Medical Histogenics (NASDAQ:HSGX) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment. Does the media favor HSGX or LAKE? In the previous week, Lakeland Industries had 7 more articles in the media than Histogenics. MarketBeat recorded 7 mentions for Lakeland Industries and 0 mentions for Histogenics. Lakeland Industries' average media sentiment score of 0.55 beat Histogenics' score of 0.00 indicating that Lakeland Industries is being referred to more favorably in the news media. Company Overall Sentiment Histogenics Neutral Lakeland Industries Positive Which has more risk & volatility, HSGX or LAKE? Histogenics has a beta of 3.1, meaning that its share price is 210% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Do analysts rate HSGX or LAKE? Lakeland Industries has a consensus price target of $28.33, indicating a potential upside of 42.31%. Given Lakeland Industries' stronger consensus rating and higher probable upside, analysts clearly believe Lakeland Industries is more favorable than Histogenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Histogenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lakeland Industries 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, HSGX or LAKE? Lakeland Industries has higher revenue and earnings than Histogenics. Lakeland Industries is trading at a lower price-to-earnings ratio than Histogenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogenicsN/AN/A-$8.64M-$0.79-0.73Lakeland Industries$151.82M1.25$5.43M-$0.09-221.22 Does the MarketBeat Community favor HSGX or LAKE? Histogenics received 156 more outperform votes than Lakeland Industries when rated by MarketBeat users. Likewise, 71.66% of users gave Histogenics an outperform vote while only 61.89% of users gave Lakeland Industries an outperform vote. CompanyUnderperformOutperformHistogenicsOutperform Votes35971.66% Underperform Votes14228.34% Lakeland IndustriesOutperform Votes20361.89% Underperform Votes12538.11% Is HSGX or LAKE more profitable? Histogenics has a net margin of 0.00% compared to Lakeland Industries' net margin of -0.42%. Lakeland Industries' return on equity of 1.66% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets HistogenicsN/A -34.96% 18.40% Lakeland Industries -0.42%1.66%1.14% Do institutionals & insiders hold more shares of HSGX or LAKE? 40.4% of Histogenics shares are held by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are held by institutional investors. 19.7% of Histogenics shares are held by insiders. Comparatively, 4.2% of Lakeland Industries shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryLakeland Industries beats Histogenics on 10 of the 17 factors compared between the two stocks. Remove Ads Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$54.56M$8.59B$5.63B$7.93BDividend YieldN/A1.38%4.89%4.05%P/E Ratio-0.7317.4523.6418.73Price / SalesN/A50.77371.04119.11Price / CashN/A19.6738.0534.64Price / Book-57.675.116.854.19Net Income-$8.64M$284.66M$3.19B$247.07M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$0.58+5.5%N/A-44.5%$54.56MN/A-0.7349LAKELakeland Industries4.8709 of 5 stars$23.13-2.0%$27.50+18.9%+34.1%$219.71M$151.82M-257.001,750Analyst ForecastShort Interest ↓News CoverageINGNInogen2.9571 of 5 stars$8.13-2.4%$7.00-13.9%+12.9%$193.64M$335.71M-3.611,030Positive NewsZJYLJin Medical InternationalN/A$0.66-3.9%N/A-87.0%$103.49M$23.50M0.00245Short Interest ↓Positive NewsGap DownMLSSMilestone ScientificN/A$1.00+6.4%$1.25+25.0%+34.9%$77.89M$8.88M-14.2830NTRBNutriband3.0334 of 5 stars$6.88-5.4%$13.00+89.0%+170.6%$76.41M$2.02M-9.6910Short Interest ↓Gap DownAPTAlpha Pro TechN/A$5.23-3.1%N/A-18.4%$57.53M$59.29M14.14120Analyst ForecastNews CoverageRBOTVicarious Surgical1.7902 of 5 stars$9.52-13.4%$10.25+7.6%-9.0%$56.26MN/A-0.933Upcoming EarningsShort Interest ↑SPAISafe Pro Group Inc. Common StockN/A$3.73-3.9%N/AN/A$51.32M$1.56M0.0011Positive NewsGap UpCLGNCollPlant Biotechnologies3.0042 of 5 stars$3.40-2.9%$12.50+267.6%-39.5%$38.95M$650,000.00-2.2170Short Interest ↓Positive NewsCOCHEnvoy Medical1.9748 of 5 stars$1.33-2.9%$8.00+501.5%-80.7%$26.93M$278,000.000.0034News CoveragePositive News Remove Ads Related Companies and Tools Related Companies LAKE Competitors INGN Competitors ZJYL Competitors MLSS Competitors NTRB Competitors APT Competitors RBOT Competitors SPAI Competitors CLGN Competitors COCH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
